Molecular Oncology
Volume 3, Issue 1 , Pages 45-53, February 2009

Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells

Department of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, T6G 1Z2, Canada

Received 5 September 2008; received in revised form 24 November 2008; accepted 27 November 2008. published online 15 December 2008.

Abstract 

Neuroglobin is a recently identified globin molecule that is expressed predominantly in the vertebrate brain. Neuroglobin expression increases in oxygen-deprived neurons, suggesting it protects neurons from ischemic cell death. We report that neuroglobin transcript and protein are expressed in human glioblastoma cells, and that this expression increases in hypoxia in vitro. We also show that neuroglobin is up-regulated in hypoxic microregions of glioblastoma tumor xenografts. Our finding of hypoxic up-regulation of neuroglobin in human glioblastoma cells may provide insight into how tumor cells adapt to and survive in hypoxic microenvironments.

Keywords: Neuroglobin, Malignant glioma, Tumor hypoxia

Abbreviations: Ngb, neuroglobin, GBM, glioblastoma multiforme, RT, reverse transcription, qRT-PCR, quantitative real-time polymerase chain reaction, SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis, HRP, horseradish peroxidase, DAB, 3,3′ diamino benzidine tetrahydrochloride, GFAP, glial fibrillary acidic protein, HIF-1, hypoxia-inducible factor-1, VEGFR2, vascular endothelial growth factor receptor 2

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(08)00149-X

doi:10.1016/j.molonc.2008.11.002

Molecular Oncology
Volume 3, Issue 1 , Pages 45-53, February 2009